Literature DB >> 33709027

Vitamin D status and disability among patients with multiple sclerosis: a systematic review and meta-analysis.

Mahmood Moosazadeh1, Fatemeh Nabinezhad-Male2, Mahdi Afshari3, Mohammad Mehdi Nasehi4, Mohammad Shabani5, Motahareh Kheradmand6, Iraj Aghaei7.   

Abstract

Association between the serum vitamin D level and disability of patients with multiple sclerosis (MS) has been investigated during several researches. However, these studies reported different results. The current study aims to estimate the correlation between the concentrations of 25 (OH) vitamin D and the level of disability among MS patients. Using Mesh and non-Mesh terms related to MS, disability level and vitamin D, different data banks were searched. Required information was extracted from the selected eligible primary articles. Stata version 11 software was applied for combining the primary correlation coefficients using random effect model. The effect of MS type and patients' age was assessed using meta-regression models. Sensitivity analysis was performed to investigate the role of each primary study in the pooled estimate. Egger test was applied to find any publication bias. Of 14 eligible studies, the total correlation coefficient (95% confidence interval) between 25 (OH) vitamin D level and disability in both sexes as well as among female was estimated as of -0.29 (-0.40, -0.17) and -0.35 (-0.46, -0.24) respectively. Two articles carried out among male did not report significant results. Our meta-analysis showed a significant negative correlation between 25 (OH) vitamin D level and disability of MS patients so that the disability reduces with increasing the 25 (OH) vitamin D level.
© 2021 the Author(s), licensee AIMS Press.

Entities:  

Keywords:  MS; disability; meta-analysis; multiple sclerosis; vitamin D

Year:  2021        PMID: 33709027      PMCID: PMC7940116          DOI: 10.3934/Neuroscience.2021013

Source DB:  PubMed          Journal:  AIMS Neurosci        ISSN: 2373-8006


  43 in total

1.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

2.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

Review 3.  Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy.

Authors:  Jin Nakahara; Michiko Maeda; Sadakazu Aiso; Norihiro Suzuki
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.

Authors:  Vittorio Martinelli; Gloria Dalla Costa; Bruno Colombo; Dacia Dalla Libera; Alessandro Rubinacci; Massimo Filippi; Roberto Furlan; Giancarlo Comi
Journal:  Mult Scler       Date:  2013-07-08       Impact factor: 6.312

Review 5.  Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Brain       Date:  2010-07       Impact factor: 13.501

Review 6.  Vitamin D and the immune system.

Authors:  Cynthia Aranow
Journal:  J Investig Med       Date:  2011-08       Impact factor: 2.895

7.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.

Authors:  Ellen M Mowry; Emmanuelle Waubant; Charles E McCulloch; Darin T Okuda; Alan A Evangelista; Robin R Lincoln; Pierre-Antoine Gourraud; Don Brenneman; Mary C Owen; Pamela Qualley; Monica Bucci; Stephen L Hauser; Daniel Pelletier
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

8.  Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.

Authors:  Karen Ann Ribbons; Patrick McElduff; Cavit Boz; Maria Trojano; Guillermo Izquierdo; Pierre Duquette; Marc Girard; Francois Grand'Maison; Raymond Hupperts; Pierre Grammond; Celia Oreja-Guevara; Thor Petersen; Roberto Bergamaschi; Giorgio Giuliani; Michael Barnett; Vincent van Pesch; Maria-Pia Amato; Gerardo Iuliano; Marcela Fiol; Mark Slee; Freek Verheul; Edgardo Cristiano; Ricardo Fernandez-Bolanos; Maria-Laura Saladino; Maria Edite Rio; Jose Cabrera-Gomez; Helmut Butzkueven; Erik van Munster; Leontien Den Braber-Moerland; Daniele La Spitaleri; Alessandra Lugaresi; Vahid Shaygannejad; Orla Gray; Norma Deri; Raed Alroughani; Jeannette Lechner-Scott
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.

Authors:  Ali Amini Harandi; Saeed Shahbeigi; Hosein Pakdaman; Seyed-Mohammad Fereshtehnejad; Elham Nikravesh; Roghie Jalilzadeh
Journal:  Iran J Neurol       Date:  2012

Review 10.  The role of vitamin D in autoimmune diseases: could sex make the difference?

Authors:  Maria Luisa Dupuis; Maria Teresa Pagano; Marina Pierdominici; Elena Ortona
Journal:  Biol Sex Differ       Date:  2021-01-12       Impact factor: 5.027

View more
  3 in total

Review 1.  Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials.

Authors:  María Dolores Guerrero Aznar; María Dolores Villanueva Guerrero; Jaime Cordero Ramos; Sara Eichau Madueño; María Morales Bravo; Rocío López Ruiz; Margarita Beltrán García
Journal:  BMC Neurol       Date:  2022-10-20       Impact factor: 2.903

Review 2.  Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide.

Authors:  Bart Van Wijmeersch; Hans-Peter Hartung; Patrick Vermersch; Maura Pugliatti; Carlo Pozzilli; Nikolaos Grigoriadis; Mona Alkhawajah; Laura Airas; Ralf Linker; Celia Oreja-Guevara
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

3.  Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies.

Authors:  Mokshal H Porwal; Ahmed Z Obeidat
Journal:  J Cent Nerv Syst Dis       Date:  2022-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.